NCT01013415View on ClinicalTrials.gov

CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

June 30, 2005

Study Completion Date

August 31, 2021

Conditions
HIV-1 Infections
Interventions
DRUG

HAART

BIOLOGICAL

T cells

Trial Locations (1)

20307

Walter Reed Army Medical Center, Washington D.C.

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT01013415 - CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients | Biotech Hunter | Biotech Hunter